ep2206497a1 atorvastatin calcium

2
Title (en) Polymorphic form of atorvastatin calcium Title (de) Polymorphe Formen von Atorvastatin calcium Title (fr) Form polymorphe de atorvastatin calcium Publication EP 2206497 A1 20100714 (EN) Application EP 10157435 A 20001116 EP 10157435 A 20001116 Priority EP 04027375 A 20001116 EP 00978744 A 20001116 US 16615399 P 19991117 Abstract (en) The present invention relates to pharmaceutical compositions and dosage forms containing atorvastatin calcium Form V. Inventor AYALON ARI (IL) LEVINGER MICHAL (IL) ROYBLAT SOFIA (IL) NIDDAM VALERIE (IL) LIFSHITZ REVITAL (IL) ARONHIME JUDITH (IL) Applicant TEVA PHARMA (IL) IPC 8 full level (invention and additional information) A61K 31/40 (2006.01); A61P 3/06 (2006.01); C07D 207/335 (2006.01); C07D 207/34 (2006.01) CPC (invention and additional information) C07D 207/34 (2013.01); A61K 31/40 (2013.01) Citation (applicant) US 4681893 A 19870721 - ROTH BRUCE D [US] US 5273995 A 19931228 - ROTH BRUCE D [US] US 5969156 A 19991019 - BRIGGS CHRISTOPHER A [US], et al GOODMAN; GILMAN: 'The Pharmacological Basis of 7herapeutics', vol. 879, 1996 Citation (search report) [A] WO 9703958 A1 19970206 - WARNER LAMBERT CO [US], et al [A] US 5273995 A 19931228 - ROTH BRUCE D [US] [A] EP 0247633 A1 19871202 - WARNER LAMBERT CO [US] [A] EP 0409281 A1 19910123 - WARNER LAMBERT CO [US] [A] WO 9416693 A1 19940804 - WARNER LAMBERT CO [US] [A] US 5969156 A 19991019 - BRIGGS CHRISTOPHER A [US], et al Designated contracting state (EPC) AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR Designated extension state (EPC) SI EPO simple patent family WO 0136384 A1 20010525; AT 288893 T 20050215; AT 478665 T 20100915; AU 1617301 A 20010530; AU 783002 B2 20050915; CA 2392096 A1 20010525; CA 2392096 C 20080715; CN 1423634 A 20030611; CZ 20021642 A3 20030514; DE 60018100 D1 20050317; DE 60018100 T2 20050915; DE 60044884 D1 20101007; EP 1235799 A1 20020904; EP 1235799 A4 20030528; EP 1235799 B1 20050209; EP 1535613 A2 20050601; EP 1535613 A3 20050831; EP 1535613 B1 20100825; EP 2206497 A1 20100714; ES 2234699 T3 20050701; ES 2349364 T3 20101230; HR P20020429 A2 20040430; HR P20020429 B1 20060531; HR P20020429 B8 20070331; HU 0203257 A2 20030128; HU 0203257 A3 20030528; IL 149681 A 20070617; IL 149681 D0 20021110; JP 2003514798 A 20030422; JP 2009102439 A 20090514; PL 355805 A1 20040517; PT 1235799 E 20050531; PT 1535613 E 20101004; SI 1235799 T1 20050630; SI 1535613 T1 20101231; SK 286789 B6 20090507; SK 6742002 A3 20030502; YU 35802 A 20050719; ZA 200203755 A 20040526 INPADOC legal status 2013-11-20 [18D] DEEMED TO BE WITHDRAWN - Effective date : 20130603 2010-09-22 [RIN1] INVENTOR (CORRECTION) - Inventor name : ARONHIME, JUDITH 2010-09-22 [RIN1] INVENTOR (CORRECTION) - Inventor name : AYALON, ARI 2010-09-22 [RIN1] INVENTOR (CORRECTION) - Inventor name : LEVINGER, MICHAL

Upload: ddscribe

Post on 26-Sep-2015

215 views

Category:

Documents


0 download

DESCRIPTION

Overview of patents associated with the anti-cholesterol compound atorvastatin calcium.

TRANSCRIPT

  • Title (en)Polymorphic form of atorvastatin calcium

    Title (de)Polymorphe Formen von Atorvastatin calcium

    Title (fr)Form polymorphe de atorvastatin calcium

    PublicationEP 2206497 A1 20100714 (EN)

    ApplicationEP 10157435 A 20001116 EP 10157435 A 20001116

    Priority EP 04027375 A 20001116 EP 00978744 A 20001116 US 16615399 P 19991117

    Abstract (en)The present invention relates to pharmaceutical compositions and dosage forms containing atorvastatin calcium Form V.

    Inventor AYALON ARI (IL) LEVINGER MICHAL (IL) ROYBLAT SOFIA (IL) NIDDAM VALERIE (IL) LIFSHITZ REVITAL (IL) ARONHIME JUDITH (IL)

    ApplicantTEVA PHARMA (IL)

    IPC 8 full level (invention and additional information)A61K 31/40 (2006.01); A61P 3/06 (2006.01); C07D 207/335 (2006.01); C07D 207/34 (2006.01)

    CPC (invention and additional information)C07D 207/34(2013.01); A61K 31/40(2013.01)

    Citation (applicant) US 4681893 A 19870721 - ROTH BRUCE D [US] US 5273995 A 19931228 - ROTH BRUCE D [US] US 5969156 A 19991019 - BRIGGS CHRISTOPHER A [US], et al

    GOODMAN; GILMAN: 'The Pharmacological Basis of 7herapeutics', vol. 879, 1996

    Citation (search report) [A]WO 9703958 A1 19970206 - WARNER LAMBERT CO [US], et al [A]US 5273995 A 19931228 - ROTH BRUCE D [US] [A]EP 0247633 A1 19871202 - WARNER LAMBERT CO [US] [A]EP 0409281 A1 19910123 - WARNER LAMBERT CO [US] [A]WO 9416693 A1 19940804 - WARNER LAMBERT CO [US] [A]US 5969156 A 19991019 - BRIGGS CHRISTOPHER A [US], et al

    Designated contracting state (EPC)AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

    Designated extension state (EPC)SI

    EPO simple patent familyWO 0136384 A1 20010525; AT 288893 T 20050215; AT 478665 T 20100915; AU 1617301 A 20010530; AU 783002 B2 20050915; CA 2392096A1 20010525; CA 2392096 C 20080715; CN 1423634 A 20030611; CZ 20021642 A3 20030514; DE 60018100 D1 20050317; DE 60018100T2 20050915; DE 60044884 D1 20101007; EP 1235799 A1 20020904; EP 1235799 A4 20030528; EP 1235799 B1 20050209; EP 1535613A2 20050601; EP 1535613 A3 20050831; EP 1535613 B1 20100825; EP 2206497 A1 20100714; ES 2234699 T3 20050701; ES 2349364 T320101230; HR P20020429 A2 20040430; HR P20020429 B1 20060531; HR P20020429 B8 20070331; HU 0203257 A2 20030128; HU 0203257A3 20030528; IL 149681 A 20070617; IL 149681 D0 20021110; JP 2003514798 A 20030422; JP 2009102439 A 20090514; PL 355805 A120040517; PT 1235799 E 20050531; PT 1535613 E 20101004; SI 1235799 T1 20050630; SI 1535613 T1 20101231; SK 286789 B6 20090507; SK6742002 A3 20030502; YU 35802 A 20050719; ZA 200203755 A 20040526

    INPADOC legal status2013-11-20 [18D] DEEMED TO BE WITHDRAWN- Effective date : 20130603

    2010-09-22 [RIN1] INVENTOR (CORRECTION)- Inventor name : ARONHIME, JUDITH

    2010-09-22 [RIN1] INVENTOR (CORRECTION)- Inventor name : AYALON, ARI

    2010-09-22 [RIN1] INVENTOR (CORRECTION)- Inventor name : LEVINGER, MICHAL

  • 2010-09-22 [RIN1] INVENTOR (CORRECTION)- Inventor name : LIFSHITZ, REVITAL

    2010-09-22 [RIN1] INVENTOR (CORRECTION)- Inventor name : NIDDAM, VALERIE

    2010-09-22 [RIN1] INVENTOR (CORRECTION)- Inventor name : ROYBLAT, SOFIA

    2010-09-15 [17Q] FIRST EXAMINATION REPORT- Effective date : 20100816

    2010-07-14 [17P] REQUEST FOR EXAMINATION FILED- Effective date : 20100331

    2010-07-14 [AC] DIVISIONAL APPLICATION (ART. 76) OF:- Ref Document Number : 1235799- Country of Ref Document : EP- Kind Code of Ref Document : P

    2010-07-14 [AC] DIVISIONAL APPLICATION (ART. 76) OF:- Ref Document Number : 1535613- Country of Ref Document : EP- Kind Code of Ref Document : P

    2010-07-14 [AK] DESIGNATED CONTRACTING STATES:- Kind Code of Ref Document : A1- Designated State(s) : AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

    2010-07-14 [AX] EXTENSION OR VALIDATION OF THE EUROPEAN PATENT TO- Countries concerned : SI